Ilypsa and Saltigo announce cooperation
Saltigo GmbH and Ilypsa, Inc. announced cooperation for process development, manufacturing and clinical supply of polymeric pharmaceutical products. This relationship initially covers process development and pre clinical and clinical supplies of Ilypsa's two lead candidates ILY101 (phosphate binder) and ILY105 (potassium binder) in the therapeutic polymer field. Working with Saltigo allows Ilypsa to take advantage of Saltigo's skills in the area of multi-step chemical synthesis which is relevant for both monomer synthesis and polymerization, both integral parts of the development program. Saltigo is also able to exploit its unique polymer process development and scale-up skills/expertise and offer Ilypsa the benefit of its multi-purpose GMP facilities and regulatory expertise which will allow supplies from early clinical trials through commercialization.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.